Ovarian Cancer Trial, Recruiting NCT06913335 Sponsor: Kafrelsheikh University Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Recruiting

NCT06913335
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older.
  • Women who have a non-cancerous cyst on one or both ovaries, identified through an ultrasound scan and normal blood test results for cancer markers.
  • Women who are considered medically suitable for keyhole (laparoscopic) surgery.

Who may not be able to join:

  • Women who are currently pregnant.
  • Women who have gone through menopause.
  • Girls who have not yet started their periods.
  • Women who have had radiotherapy to the pelvic or abdominal area recently.
  • Women who have serious ongoing conditions affecting other body systems.
  • Women where an ovarian cancer has been identified or suspected through ultrasound or blood tumor marker tests.
  • Women who have problems with blood clotting or bleeding disorders.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 01097659005

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Kafrelsheikh University
Registry
ClinicalTrials.gov
Start date
1 April 2025
Est. completion
1 April 2026

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

The primary outcome of this study will be the hemostasis time

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov